ImageneBio Inc (IMA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -14.8M | -7.22M | -26.64M | -3.42M | -10.56M | -6.26M | -8.94M | -12.5M | -18.3M | -21.82M | -20M | -18.14M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | -3310.93% | -1687.51% | -905.34% |
| Operating CF Growth % | -40.13% | -15.3% | -198.08% | 72.63% | 42.3% | 71.31% | 55.3% | 31.09% | 7.48% | -23.59% | -16.13% | 6.72% |
| Net Income | -10.62M | -6.91M | -24.78M | -2.77M | -8.62M | -9.12M | -10.23M | -13.73M | -16.15M | -19.49M | -17.34M | -17.11M |
| Depreciation & Amortization | 174K | 355K | 0 | 87K | 87K | 89K | 90K | 92K | 219K | 305K | 242K | 586K |
| Stock-Based Compensation | 876K | 51K | 0 | 458K | 904K | 998K | 1.02M | 1.28M | 2M | 1.75M | 2M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -7K | 168K | 11.48M | 494K | 337K | 240K | 253K | 38K | 893K | 1.99M | -106K | 1.28M |
| Working Capital Changes | -5.22M | -884K | -13.34M | -1.69M | -3.27M | 1.54M | -64K | -181K | -5.27M | -6.38M | -4.79M | -2.9M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 132K | -501K | -157K | -1.88M | -666K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -871K | -641K | -1.79M | -293K | -92K | -643K | 0 | 0 | 0 | 0 | 0 | -987K |
| Cash from Investing | -440K | -1.36M | -37.33M | 24.95M | 7.93M | 463K | 9.45M | 3.92M | -48.74M | 20.38M | 31.89M | 22.68M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -262K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | 39.76% | - | - |
| Acquisitions | 0 | 0 | -5.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 15M | -15M | 0 | -7.5M | 190K | 185K | 60K | -4K | 0 | 0 |
| Cash from Financing | -3.24M | 0 | 135.47M | 0 | 0 | 0 | 0 | 0 | 0 | 60K | 38.92M | 37M |
| Debt Issued (Net) | 0 | 0 | 15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -3.24M | 0 | 65.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -123K | 37M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -663K |
| Other Financing | 0 | 0 | 54.63M | 0 | 0 | 0 | 0 | 0 | 0 | 60K | 39.04M | 0 |
| Net Change in Cash | -18.48M | -8.63M | 44.87M | 21.53M | -2.63M | -5.8M | 516K | -8.58M | -67.04M | -1.38M | 50.81M | 41.54M |
| Free Cash Flow | -14.8M | -7.22M | -26.64M | -3.42M | -10.56M | -6.26M | -8.94M | -12.5M | -18.3M | -22.08M | -20M | -18.14M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | -3350.68% | -1687.51% | -905.34% |
| FCF Growth % | -40.13% | -15.3% | -198.08% | 72.63% | 42.3% | 71.65% | 55.3% | 31.09% | 8.19% | -23.45% | -8.98% | 6.9% |
| FCF per Share | -1.32 | -0.65 | -3.12 | -0.07 | -0.22 | -0.13 | -0.19 | -0.26 | -0.38 | -0.46 | -0.46 | -0.42 |
| FCF Conversion (FCF/Net Income) | 1.39x | 1.04x | 1.08x | 1.24x | 1.23x | 0.69x | 0.87x | 0.91x | 1.13x | 1.12x | 1.15x | 1.06x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |